We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lymphocyte Membrane Antigen Receptors Reside in Discrete Protein Islands

By LabMedica International staff writers
Posted on 27 Sep 2015
Image: Researchers previously assumed that receptors such as the antigen receptors of class Immunoglobulin M and Immunoglobulin D are freely diffusing and equally distributed molecules on the membrane. However, the new study shows that these antigen receptors are organized in different membrane compartments, also called \"protein islands\", with diameters of 150–200 nanometers (Photo courtesy of Reth Research Group, BIOSS Centre for Biological Signaling Studies of the University of Freiburg).
Image: Researchers previously assumed that receptors such as the antigen receptors of class Immunoglobulin M and Immunoglobulin D are freely diffusing and equally distributed molecules on the membrane. However, the new study shows that these antigen receptors are organized in different membrane compartments, also called \"protein islands\", with diameters of 150–200 nanometers (Photo courtesy of Reth Research Group, BIOSS Centre for Biological Signaling Studies of the University of Freiburg).
By applying several advanced imaging techniques, researchers have resolved the distribution of B-cell antigen receptors on the membranes of immune system lymphocytes.

The B-cell antigen receptors (BCRs) play an important role in the clonal selection of B-cells and their differentiation into antibody-secreting plasma cells. Mature B-cells have both immunoglobulin M (IgM) and IgD types of BCRs, which have identical antigen-binding sites and are both associated with the signaling subunits Ig-alpha and Ig-beta, but differ in their membrane-bound heavy chain isoforms.

Investigators at the BIOSS Centre for Biological Signaling Studies of the University of Freiburg (Germany) applied, two-color direct stochastic optical reconstruction microscopy (dSTORM), transmission electron microscopy (TEM), and the Fab-based proximity-ligation assay (Fab-PLA) to resolve the location and distribution of BCRs in the mature lymphocyte membrane.

Results published in the September 15, 2015, issue of the journal Science Signaling revealed that in contrast to the assumption that BCRs—like all proteins in the membrane—were freely diffusing molecules, dSTORM showed that IgM-BCRs and IgD-BCRs resided in the plasma membrane in different protein islands with average sizes of 150 and 240 nanometers, respectively. Upon B-cell activation, the BCR protein islands became smaller and more dispersed such that the IgM-BCRs and IgD-BCRs were found in close proximity to each other. Moreover, specific stimulation of one class of BCR had minimal effects on the organization of the other. These conclusions were supported by the findings from two-marker transmission electron microscopy and proximity ligation assays.

These results provide direct evidence for the nanoscale compartmentalization of the lymphocyte membrane. In addition, they suggest that upon B-cell activation, the different IgM and IgD protein islands form complexes, which allow the exchange of lipids and proteins. This could be the basis for the association of IgM with Raft-associated lipids and proteins, which is a well-known hallmark of B-cell activation.

The current study was a component of the University of Frieberg's BIOSS nanoscale explorer program (BiNEP), which is dedicated to developing better methods to resolve nano-structures that are smaller than the 250 nanometer diffraction limit of visible light.

Related Links:
BIOSS Centre for Biological Signaling Studies of the University of Freiburg


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel

DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
PURITAN MEDICAL